NCT06566859

Brief Summary

Relieving postoperative nephrectomy pain requires multimodal approaches. Peripheral blocks such as ESP block and M-TAPA block and multimodal analgesics reduce side effects by reducing the use of other analgesics. This study aimed to compare the effectiveness of erector spinae plane block (ESP block) and modified thoracoabdominal nerve blocking with perichondrial approach (M-TAPA block) in postoperative analgesia management in nephrectomy cases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

August 11, 2024

Last Update Submit

August 20, 2024

Conditions

Keywords

nerve blockpain managementpostoperative periodpostoperative complicationsregional anesthesiapain

Outcome Measures

Primary Outcomes (6)

  • Postoperative Pain Management

    The primary outcome of this study is to demonstrate that Modified Thoracoabdominal Nerves Block(M-TAPA) contributes sufficiently to multimodal analgesia in perioperative analgesia in nephrectomy surgery.This contribution will be evaluated with the NRS. NRS is a unidimensional scale in which 11 numbers (between 0 and 10) are used to measure pain intensity. The patient is asked to choose the number that best reflects the pain intensity, with 0 = no pain and 10 = worst (unbearable) pain.

    0.hour

  • Postoperative Pain Management

    The primary outcome of this study is to demonstrate that Modified Thoracoabdominal Nerves Block(M-TAPA) contributes sufficiently to multimodal analgesia in perioperative analgesia in nephrectomy surgery.This contribution will be evaluated with the NRS. NRS is a unidimensional scale in which 11 numbers (between 0 and 10) are used to measure pain intensity. The patient is asked to choose the number that best reflects the pain intensity, with 0 = no pain and 10 = worst (unbearable) pain.

    6.hour

  • Postoperative Pain Management

    The primary outcome of this study is to demonstrate that Modified Thoracoabdominal Nerves Block(M-TAPA) contributes sufficiently to multimodal analgesia in perioperative analgesia in nephrectomy surgery.This contribution will be evaluated with the NRS. NRS is a unidimensional scale in which 11 numbers (between 0 and 10) are used to measure pain intensity. The patient is asked to choose the number that best reflects the pain intensity, with 0 = no pain and 10 = worst (unbearable) pain.

    12.hour

  • Postoperative Pain Management

    The primary outcome of this study is to demonstrate that Modified Thoracoabdominal Nerves Block(M-TAPA) contributes sufficiently to multimodal analgesia in perioperative analgesia in nephrectomy surgery.This contribution will be evaluated with the NRS. NRS is a unidimensional scale in which 11 numbers (between 0 and 10) are used to measure pain intensity. The patient is asked to choose the number that best reflects the pain intensity, with 0 = no pain and 10 = worst (unbearable) pain.

    24.hour

  • Postoperative Pain Management

    Total amount of analgesic used in 24 hours

    24 hours

  • Postoperative Pain Management

    Time of first additional analgesic requirement up to 24 hours

    24 hours

Study Arms (2)

M-TAPA Block

Patients who have standard anesthesia are randomized with the research randomizer application while under anesthesia and M-TAPA block is applied under ultrasound guidance in the preoperative period. For the block, 50 mg of 0.25% bupivacaine and 100 mg lidocaine are injected, totaling 20cc.

Other: NRS 0. hourOther: NRS 6. HourOther: NRS 12. HourOther: NRS 24. Hour

ESP Block

Patients who have standard anesthesia are randomized with the research randomizer application while under anesthesia and ESP block is applied under ultrasound guidance in the preoperative period. For the block, 50 mg of 0.25% bupivacaine and 100 mg lidocaine are injected, totaling 20cc.

Other: NRS 0. hourOther: NRS 6. HourOther: NRS 12. HourOther: NRS 24. Hour

Interventions

Numerical rating scala

ESP BlockM-TAPA Block

Numerical rating scala

ESP BlockM-TAPA Block

Numerical rating scala

ESP BlockM-TAPA Block

Numerical rating scala

ESP BlockM-TAPA Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients aged 18 and over with ASA1-2 who underwent elective nephrectomy. .

You may qualify if:

  • All patients aged 18 and over with ASA1-2 who underwent elective nephrectomy

You may not qualify if:

  • ASA ≥3
  • Body mass index\>35 kg/ m²
  • Infection in the block area
  • Coagulation disorder,
  • Known allergy to local anesthetics
  • Pregnant
  • Patient with neuropathy
  • Patient without cooperation
  • Patient who refuses to participate in the study
  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BasaksehirCamSakuraH

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosiaPostoperative ComplicationsPain

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Hilal Akça

    BasaksehirCamSakuraH

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 11, 2024

First Posted

August 22, 2024

Study Start

September 1, 2024

Primary Completion

February 1, 2025

Study Completion

February 1, 2025

Last Updated

August 22, 2024

Record last verified: 2024-08

Locations